by Team Small News | Mar 21, 2025 | Biocon, Pharma
Biocon, an Indian generic drug manufacturer, has been hit with a patent infringement complaint in the US District of New Jersey by Impax Laboratories. The complaint is related to Biocon’s Abbreviated New Drug Application (ANDA) to sell a generic version of the... by Team Small News | Mar 18, 2025 | Biocon, Pharma
Johor has emerged as a prime location to become Asia’s largest insulin hub, with Indian biotech major Biocon’s RM1.1 billion (approximately US$274 million) investment to establish a manufacturing facility in the state. Biocon, one of India’s largest...